Director Robert H. Niehaus purchases 30,000 IRDM shares at $17.49; stock down 48.2% from 52-week high of $32.66.
Director Niehaus acquired 30,000 shares of Iridium Communications Inc. at $17.49 on 2025-10-28, increasing his holdings by 11.2% to 297,362 shares. The transaction occurs with the stock trading -48.2% from its 52-week high and down -30.8% over the past 90 days, suggesting the purchase coincides with material price weakness. His cross-ticker track record shows 1 prior buy with a 100% 90-day win rate and average 90-day return of +18.3%, though this buy-timing success does not yet apply to his same-ticker history at IRDM, where all 3 prior trades were sells. The company trades at a P/E of 14.11 with positive fundamentals: $226.9M in latest quarterly revenue, $37.1M net income, and +5.0% annual revenue growth. The decision to accumulate shares while the stock is near its 52-week low and after sustained declines suggests evaluation of value relative to current price levels, but the significance remains moderate given the sustained downtrend and lack of near-term bullish catalysts visible in the filing.
Director NIEHAUS buys 30,000 ZETA shares at $18.62; 6 other insiders bought within 14 days amid -21.1% 30-day decline.
NIEHAUS ROBERT H purchased 30,000 shares at $18.62 on 2024-11-18, increasing his holdings from 278.6K to 308.6K shares (+10.8%). This transaction occurred as ZETA traded -21.1% over the prior 30 days and -40.1% from its 52-week high of $36.74. Most significantly, a cluster of 6 other insiders bought within the same 14-day window, suggesting coordinated confidence during a period of material price weakness. The company remains unprofitable (net income $-17.4M in the latest quarter) despite strong revenue growth of +23.3% year-over-year, leaving fundamental context mixed. The convergence of multi-insider buying amid both sharp price decline and unresolved profitability creates a signal warranting investor scrutiny of management's conviction relative to near-term execution risks.
IRDM director Niehaus sold 38,355 shares at $29.39; price now $28.94, -29.9% from 52-week high.
Director Robert H Niehaus sold 38,355 shares on 2024-10-23 at $29.39, reducing his holdings by 13.1%. His prior two sales at Iridium showed well-timed execution, with 90-day returns of -14.8% and -16.1% respectively, both negative outcomes that validated the timing of those sales. The current share price of $28.94 is now 29.9% below the 52-week high of $41.26, suggesting the stock has deteriorated significantly since this transaction. While the company shows solid fundamentals with $212.8M quarterly revenue, +9.7% annual growth, and $24.4M net income, the director's measured reduction in a now-depressed position follows a consistent pattern of well-timed exits at this ticker.
